- Ticker
- CNTX
- Price
- 2.09
- Stock movement down
- -0.06 (-2.79%)
- Company name
- Context Therapeutics Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 156.75M
- Ent value
- 149.27M
- Price/Sales
- 8270.71
- Price/Book
- 18.56
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- 104.90%
- 3 year return
- -
- 5 year return
- -
- 10 year return
- -
Last updated: 2024-09-13
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
CNTX does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 8270.71 |
| Price to Book | 18.56 |
| EV to Sales | 7875.99 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 75.00M |
| EPS (TTM) | -1.34 |
| FCF per share (TTM) | -1.23 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 18.95K |
| Gross profit (TTM) | 7.53K |
| Operating income (TTM) | -22.23M |
| Net income (TTM) | -21.32M |
| EPS (TTM) | -1.34 |
| EPS (1y forward) | -0.32 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 39.75% |
| Operating margin (TTM) | -117294.02% |
| Profit margin (TTM) | -112514.19% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 10.09M |
| Net receivables | 0.00 |
| Total current assets | 11.04M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 11.05M |
| Accounts payable | 2.05M |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 2.61M |
| Total liabilities | 2.61M |
| Shareholder's equity | 8.44M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -19.68M |
| Capital expenditures (TTM) | 0.00 |
| Free cash flow (TTM) | -19.68M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -252.55% |
| Return on Assets | -192.95% |
| Return on Invested Capital | -252.55% |
| Cash Return on Invested Capital | -233.08% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 2.21 |
| Daily high | 2.23 |
| Daily low | 2.03 |
| Daily Volume | 69K |
| All-time high | 7.45 |
| 1y analyst estimate | 5.40 |
| Beta | 2.32 |
| EPS (TTM) | -1.34 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| CNTX | S&P500 | |
| Current price drop from All-time high | -71.95% | -0.50% |
| Highest price drop | -93.53% | -56.47% |
| Date of highest drop | 4 May 2023 | 9 Mar 2009 |
| Avg drop from high | -77.60% | -11.22% |
| Avg time to new high | 243 days | 12 days |
| Max time to new high | 725 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
156.75M
Marketcap category
Small-cap
Description
Context Therapeutics Inc., a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. The company has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of a CLDN6 bispecific monoclonal antibody for cancer therapy. Context Therapeutics Inc. was incorporated in 2015 and is headquartered in Philadelphia, Pennsylvania.
Employees
5
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page